Daily policy & regulation roundup: 6 stories curated October 26, 2026. Lead: Recon: FDA approves Edwards’ tricuspid valve repair device; Bayer wins Chinese approval fo.

The latest in policy & regulation: 6 developments from the past day, tracked and curated by the HealthTech Cube news desk. The lead story: Recon: FDA approves Edwards’ tricuspid valve repair device; Bayer wins Chinese approval for blood thinner asundexian.
Enrollees must jump through more hoops to verify their income and residency status before receiving subsidies for Affordable Care Act plans. Over 300,000 enrollees are expected to leave each year as a result.
Follow the full firehose on the HTC Wire, refreshed automatically every day.